Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Third Harmonic Bio: Q3 Earnings Insights

Third Harmonic Bio (NASDAQ:THRD) reported its Q3 earnings results on Thursday, November 9, 2023 at 04:00 PM. Here’s…
byBenzinga Insights
November 9, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Third Harmonic Bio (NASDAQ:THRD) reported its Q3 earnings results on Thursday, November 9, 2023 at 04:00 PM.

Here’s what investors need to know about the announcement.

Earnings

Third Harmonic Bio missed estimated earnings by 125.93%, reporting an EPS of $-0.61 versus an estimate of $-0.27.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.11 which was followed by a 0.64% increase in the share price the next day.

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for Third Harmonic Bio visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

What’s Going On With Palantir’s Stock?

By Erica Kollmann
May 9, 11:52 AM
Palantir's first-quarter revenue increased 21% year-over-year to $634 million, beating the consensus estimate. However, the stock tumbled as investors reacted negatively to the company's light guidance for the second quarter and the full year. CNBC's Jim Cramer said he still believes Palantir is a strong company following the earnings report. "I like that conference call very, very much," Cramer said. "I say not to worry, that company is a good company to own right here, right now."

ARKF